U.S. markets close in 1 hour 22 minutes

WuXi AppTec Co., Ltd. (603259.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
72.55+1.75 (+2.47%)
At close: 03:00PM CST

WuXi AppTec Co., Ltd.

288 Fute Zhong Road
Waigaoqiao Free Trade Zone
Shanghai 200131
86 21 5046 1111

IndustryDiagnostics & Research
Full Time Employees39,716

Key Executives

NameTitlePayExercisedYear Born
Dr. Ge Li Ph.D.Co-Founder, Chairman, Pres & CEON/AN/A1967
Dr. Minzhang Chen Ph.D.Co-Chief Exec. Officer & Exec. DirectorN/AN/A1970
Dr. Qing Yang Ph.D.Co-CEO & Exec. DirectorN/AN/A1970
Dr. Edward Hu M.B.A.Vice Chairman & Global Chief Investment OfficerN/AN/A1963
Ms. Ming ShiSr. VP & CFON/AN/A1975
Dr. Shuhui Chen Ph.D.Chief Scientific Officer & Exec. VPN/AN/A1964
Mr. Kyler LeiIR DirectorN/AN/AN/A
Mr. Yao ChiJoint Company Sec. & Exec. Director of the Corp. Legal OfficeN/AN/A1983
Dr. Howard Wu J.D.Sr. VP, Gen. Counsel & Global Head of HRN/AN/AN/A
Mr. Zhaohui ZhangCOO of China, Exec. VP & DirectorN/AN/A1970
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.


WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.

Corporate Governance

WuXi AppTec Co., Ltd.’s ISS Governance QualityScore as of September 1, 2022 is 2. The pillar scores are Audit: 1; Board: 2; Shareholder Rights: 5; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.